Cellular and molecular aspects of familial hypertrophic cardiomyopathy caused by mutations in the cardiac troponin I gene

Molecular and Cellular Biochemistry

Volumn 263, Issue 1, 2004, Pages 99-114

  Gomes, Aldrin V ^a   Potter, James D ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Cardiac; Familial hypertrophic cardiomyopathy; Muscle contraction and calcium; Toponin I

Indexed keywords

CALCIUM ION; TROPONIN I;

AMINO ACID SEQUENCE; ARTICLE; CLINICAL FEATURE; DISEASE SEVERITY; ENVIRONMENTAL FACTOR; FAMILIAL HYPERTROPHIC CARDIOMYOPATHY; GENE FUNCTION; GENE MUTATION; HEART FAILURE; HEART HEMODYNAMICS; HEART LEFT VENTRICLE; HEART MUSCLE CONTRACTILE FORCE; HEART MUSCLE RELAXATION; HEART PERFORMANCE; HEREDITY; HUMAN; IN VITRO STUDY; LIFE EXPECTANCY; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; SUDDEN DEATH; SYMPTOMATOLOGY;

AMINO ACID SEQUENCE; ANIMALS; ARGININE; BASE SEQUENCE; BINDING SITES; CALCIUM; CARDIOMYOPATHY, HYPERTROPHIC, FAMILIAL; CODON; DNA; HUMANS; MICE; MICE, TRANSGENIC; MOLECULAR SEQUENCE DATA; MUTATION; MUTATION, MISSENSE; MYOCARDIAL CONTRACTION; PHENOTYPE; PHOSPHORYLATION; SEQUENCE DELETION; SEQUENCE HOMOLOGY, AMINO ACID; TROPONIN I;

EID: 4544291412     PISSN: 03008177     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:MCBI.0000041852.42291.aa     Document Type: Article

References (81)

1. Geisterfer-Lowrance AA, Kass S, Tanigawa G, Vosberg HP, McKenna W, Seidman CE, Seidman JG: A molecular basis for familial hypertrophic cardiomyopathy: A beta cardiac myosin heavy chain gene missense mutation. Cell 62: 999-1006, 1990
2. Poetter K, Jiang H, Hassanzadeh S, Master SR, Chang A, Dalakas MC, Rayment I, Sellers JR, Fananapazir L, Epstein ND: Mutations in either the essential or regulatory light chains of myosin are associated with a rare myopathy in human heart and skeletal muscle. Nat Genet 13: 63-69, 1996
3. Thierfelder L, Watkins H, MacRae C, Lamas R, McKenna W, Vosberg HP, Seidman JG, Seidman CE: Alpha-tropomyosin and cardiac troponin T mutations cause familial hypertrophic cardiomyopathy: A disease of the sarcomere. Cell 77: 701-712, 1994
4. Bonne G, Carrier L, Bercovici J, Cruaud C, Richard P, Hainque B, Gautel M, Labeit S, James M, Beckmann J, Weissenbach J, Rosberg HP, Fiszman M, Kanajda M, Schwartz K: Cardiac myosin binding protein-C gene splice acceptor site mutation is associated with familial hypertrophic cardiomyopathy. Nat Genet 11: 438-440, 1995
5. Watkins H, Conner D, Thierfelder L, Jarcho JA, MacRae C, McKenna WJ, Maron BJ, Seidman JG, Seidman CE: Mutations in the cardiac myosin binding protein-C gene on chromosome 11 cause familial hypertrophic cardiomyopathy. Nat Genet 11:434-437, 1995
6. Kimura A, Harada H, Park JE, Nishi H, Satoh M, Takahashi M, Hiroi S, Sasaoka T, Ohbuchi N, Nakamura T, Koyanagi T, Hwang TH, Choo JA, Chung KS, Hasegawa A, Nagai R, Okazaki O, Nakamura H, Matsuzaki M, Sakamoto T, Toshima H, Koga Y, Imaizumi T, Sasazuki T: Mutations in the cardiac troponin I gene associated with hypertrophic cardiomyopathy. Nat Genet 16: 379-382, 1997
7. Mogensen J, Klausen IC, Pedersen AK, Egeblad H, Bross P, Kruse TA, Gregersen N, Hansen PS, Baandrup U, Borglum AD: Alpha-cardiac actin is a novel disease gene in familial hypertrophic cardiomyopathy. J Clin Invest 103: R39-R43, 1999
8. Satoh M, Takahashi M, Sakamoto T, Hiroe M, Marumo F, Kimura A: Structural analysis of the titin gene in hypertrophic cardiomyopathy: Identification of a novel disease gene. Biochem Biophys Res Commun 262: 411-417, 1999
9. Hoffmann B, Schmidt-Traub H, Perrot A, Osterziel KJ, Gessner R: First mutation in cardiac troponin C, L29Q, in a patient with hypertrophic cardiomyopathy. Hum Mutat 17: 524, 2001
10. Maron BJ, Gardin JM, Flack JM, Gidding SS, Kurosaki TT, Bild DE: Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA Study. Coronary artery risk development in (young) adults. Circulation 92: 785-789, 1995
11. Vallins WJ, Brand NJ, Dabhade N, Butler-Browne G, Yacoub MH, Barton PJ: Molecular cloning of human cardiac troponin I using polymerase chain reaction. FEBS Lett 270: 57-61, 1990
12. Bhavsar PK, Brand NJ, Yacoub MH, Barton PJ: Isolation and characterization of the human cardiac troponin I gene (TNNI3). Genomics 35: 11-23, 1996
13. Bermingham N, Hernandez D, Balfour A, Gilmour F, Martin JE, Fisher EM: Mapping TNNC1, the gene that encodes cardiac troponin I in the human and the mouse. Genomics 30: 620-622, 1995
14. Zot AS, Potter JD: Structural aspects of troponin-tropomyosin regulation of skeletal muscle contraction. Annu Rev Biophys Biophys Chem 16: 535-559, 1987
15. Solaro RJ, Rarick HM: Troponin and tropomyosin: Proteins that switch on and tune in the activity of cardiac myofilaments. Circ Res 83: 471-480, 1998
16. Anderson PA, Greig A, Mark TM, Malouf NN, Oakeley AE, Ungerleider RM, Allen PD, Kay BK: Molecular basis of human cardiac troponin T isoforms expressed in the developing, adult, and failing heart. Circ Res 76: 681-686, 1995
17. Sasse S, Brand NJ, Kyprianou P, Dhoot GK, Wade R, Arai M, Periasamy M, Yacoub MH, Barton PJ: Troponin I gene expression during human cardiac development and in end-stage heart failure. Circ Res 72: 932-938, 1993
18. Perry SV: Troponin I: Inhibitor or facilitator. Mol Cell Biochem 190: 9-32, 1999
19. Pi Y, Kemnitz KR, Zhang D, Kranias EG, Walker JW: Phosphorylation of troponin I controls cardiac twitch dynamics: Evidence from phosphorylation site mutants expressed on a troponin I-null background in mice. Circ Res 90: 649-656, 2002
20. 2+ saturated form. Nature 424: 35-41, 2003
21. Cabral-Lilly D, Tobacman LS, Mehegan JP, Cohen C: Molecular polarity in tropomyosin-troponin T co-crystals. Biophys J 73: 1763-1770, 1997
22. 2- and COOH-terminal domains of troponin T. ATPase activation and binding to troponin I and troponin C. J Biol Chem 273: 10594-10601, 1998
23. Oliveira DM, Nakaie CR, Sousa AD, Farah CS, Reinach FC: Mapping the domain of troponin T responsible for the activation of actomyosin ATPase activity. Identification of residues involved in binding to actin. J Biol Chem 275: 27513-27519, 2000
24. Stefancsik R, Jha PK, Sarkar S: Identification and mutagenesis of a highly conserved domain in troponin T responsible for troponin I binding: Potential role for coiled coil interaction. Proc Natl Acad Sci USA 95: 957-962, 1998
25. Geeves MA, Lehrer SS: Dynamics of the muscle thin filament regulatory switch: The size of the cooperative unit. Biophys J 67: 273-282, 1994
26. Lehrer SS, Geeves MA: The muscle thin filament as a classical cooperative/allosteric regulatory system. J Mol Biol 277: 1081-1089, 1998
27. Squire JM, Morris EP: A new look at thin filament regulation in vertebrate skeletal muscle. Faseb J 12: 761-771, 1998
28. Luo Y, Leszyk J, Li B, Li Z, Gergely J, Tao T: Troponin-I interacts with the Met47 region of skeletal muscle actin. Implications for the mechanism of thin filament regulation by calcium. J Mol Biol 316: 429-434, 2002
29. Kokado H, Shimizu M, Yoshio H, Ino H, Okeie K, Emoto Y, Matsuyama T, Yamaguchi M, Yasuda T, Fujino N, Ito H, Mabuchi H: Clinical features of hypertrophic cardiomyopathy caused by a Lys183 deletion mutation in the cardiac troponin I gene. Circulation 102: 663-669, 2000
30. Morner S, Richard P, Kazzam E, Hainque B, Schwartz K, Waldenstrom A: Deletion in the cardiac troponin I gene in a family from northern Sweden with hypertrophic cardiomyopathy. J Mol Cell Cardiol 32: 521-525, 2000
31. Genomics of Cardiovascular Development A, and Remodeling: NHLBI Program for Genomic Applications, Beth Israel Deaconess Medical Center. Available at http://www.cardiogenomics.org, Aug 2003
32. Ellsworth EG, Van Driest SL, Nishimura RA, Gersh BJ, Tajik AJ, Ommen SR, Ackerman MJ: Prevalence and spectrum of cardiac troponin I mutations in hypertrophic cardiomyopathy. Circulation 106: II-289, 2002
33. Mogensen J, Klausen IC, Egeblad H, Baandrup U, Borglum AD: Sudden cardiac death in familial hypertrophic cardiomyopathy is associated with a novel mutation in the troponin I gene. Circulation 100: I-618, 1999
34. Richard P, Charron P, Carrier L, Ledeuil C, Cheav T, Pichereau C, Benaiche A, Isnard R, Dubourg O, Burban M, Gueffet JP, Millaire A, Desnos M, Schwartz K, Hainque B, Komajda M. Hypertrophic Cardiomyopathy. Distribution of disease genes, spectrum of mutations, and implications for a molecular diagnosis strategy. Circulation 107: 2227-2232, 2003
35. Niimura H, Patton KK, McKenna WJ, Soults J, Maron BJ, Seidman JG, Seidman CE: Sarcomere protein gene mutations in hypertrophic cardiomyopathy of the elderly. Circulation 105: 446-451, 2002
36. Shimizu M, Ino H, Yamaguchi M, Terai H, Hayashi K, Kiyama M, Sakata K, Hayashi T, Inoue M, Kaneda T, Mabuchi H: Chronologic electrocardiographic changes in patients with hypertrophic cardiomyopathy associated with cardiac troponin 1 mutation. Am Heart J 143: 289-293, 2002
37. McKenna WJ, Spirito P, Desnos M, Dubourg O, Komajda M: Experience from clinical genetics in hypertrophic cardiomyopathy: Proposal for new diagnostic criteria in adult members of affected families. Heart 77: 130-132, 1997
38. Gollob MH, Green MS, Tang AS, Gollob T, Karibe A, Ali Hassan AS, Ahmad F, Lozado R, Shah G, Fananapazir L, Bachinski LL, Roberts R, Hassan AS: Identification of a gene responsible for familial Wolff-Parkinson-White syndrome. N Engl J Med 344: 1823-1831, 2001
39. Lang R, Gomes AV, Zhao J, Housmans PR, Miller T, Potter JD: Functional analysis of a troponin I (Arg145Gly) mutation associated with familial hypertrophic cardiomyopathy. J Biol Chem 277: 11670-11678, 2002
40. Takahashi-Yanaga F, Morimoto S, Ohtsuki I: Effect of Arg145Gly mutation in human cardiac troponin I on the ATPase activity of cardiac myofibrils. J Biochem (Tokyo) 127: 355-357, 2000
41. Takahashi-Yanaga F, Morimoto S, Harada K, Minakami R, Shiraishi F, Ohta M, Lu QW, Sasaguri T, Ohtsuki I: Functional consequences of the mutations in human cardiac troponin I gene found in familial hypertrophic cardiomyopathy. J Mol Cell Cardiol 33: 2095-2107, 2001
42. Elliott K, Watkins H, Redwood CS: Altered regulatory properties of human cardiac troponin I mutants that cause hypertrophic cardiomyopathy. J Biol Chem 275: 22069-22074, 2000
43. Burton D, Abdulrazzak H, Knott A, Elliott K, Redwood C, Watkins H, Marston S, Ashley C: Two mutations in troponin I that cause hypertrophic cardiomyopathy have contrasting effects on cardiac muscle contractility. Biochem J 362: 443-451, 2002
44. James J, Zhang Y, Osinska H, Sanbe A, Klevitsky R, Hewett TE, Robbins J: Transgenic modeling of a cardiac troponin I mutation linked to familial hypertrophic cardiomyopathy. Circ Res 87: 805-811, 2000
45. Armour KL, Harris WJ, Tempest PR: Cloning and expression in Escherichia coli of the cDNA encoding human cardiac troponin I. Gene 131: 287-292, 1993
46. Zhang R, Zhao J, Mandveno A, Potter JD: Cardiac troponin I phosphorylation increases the rate of cardiac muscle relaxation. Circ Res 76: 1028-1035, 1995
47. Kentish JC, McCloskey DT, Layland J, Palmer S, Leiden JM, Martin AF, Solaro RJ: Phosphorylation of troponin I by protein kinase A accelerates relaxation and crossbridge cycle kinetics in mouse ventricular muscle. Circ Res 88: 1059-1065, 2001
48. Reiffert SU, Jaquet K, Heilmeyer LM, Jr., Herberg FW: Stepwise sub-unit interaction changes by mono- and bis-phosphorylation of cardiac troponin I. Biochemistry 37: 13516-13525, 1998
49. Dohet C, al-Hillawi E, Trayer IP, Ruegg JC: Reconstitution of skinned cardiac fibres with human recombinant cardiac troponin-I mutants and troponin-C. FEBS Lett 377: 131-134, 1995
50. Quirk PG, Patchell VB, Gao Y, Levine BA, Perry SV: Sequential phosphorylation of adjacent serine residues on the N-terminal region of cardiac troponin-I: Structure-activity implications of ordered phosphorylation. FEBS Lett 370: 175-178, 1995
51. Deng Y, Schmidtmann A, Redlich A, Westerdorf B, Jaquet K, Thieleczek R: Effects of phosphorylation and mutation R145G on human cardiac troponin I function. Biochemistry 40: 14593-14602, 2001
52. Montgomery DE, Wolska BM, Pyle WG, Roman BB, Dowell JC, Buttrick PM, Koretsky AP, Del Nido P, Solaro RJ: Alpha-adrenergic response and myofilament activity in mouse hearts lacking PKC phosphorylation sites on cardiac TnI. Am J Physiol Heart Circ Physiol 282: H2397-H2405, 2002
53. 2+-stimulated MgAT-Pase of reconstituted actomyosin S-1. J Biol Chem 270: 25445-25454, 1995
54. Lindhout DA, Li MX, Schieve D, Sykes BD: Effects of T142 phosphorylation and mutation R145G on the interaction of the inhibitory region of human cardiac troponin I with the C-domain of human cardiac troponin C. Biochemistry 41: 7267-7274, 2002
55. Li MX, Wang X, Buscemi N, Van Eyk JE, Sykes BD: Novel phosphorylation of Ser 149 in cardiac troponin I (cTnI) by PAK reduces the affinity of cTnI for cardiac troponin C (cTnC). Biophys J 82: 389A, 2002
56. Ruse CI, Willard B, Jin JP, Haas T, Kinter M, Bond M: Kinetics and stoichiometry of protein phosphorylation at the amino acid level. Biophys J 82: 389A, 2002
57. Ramos CH: Mapping subdomains in the C-terminal region of troponin I involved in its binding to troponin C and to thin filament. J Biol Chem 274: 18189-18195, 1999
58. Vassylyev DG, Takeda S, Wakatsuki S, Maeda K, Maeda Y: Crystal structure of troponin C in complex with troponin I fragment at 2.3-Å resolution. Proc Natl Acad Sci USA 95: 4847-4852, 1998
59. Ferrieres G, Pugniere M, Mani JC, Villard S, Laprade M, Doutre P, Pau B, Granier C: Systematic mapping of regions of human cardiac troponin I involved in binding to cardiac troponin C: N- and C-terminal low affinity contributing regions. FEBS Lett 479: 99-105, 2000
60. Li MX, Saude EJ, Wang X, Pearlstone JR, Smillie LB, Sykes BD: Kinetic studies of calcium and cardiac troponin I peptide binding to human cardiac troponin C using NMR spectroscopy. Eur Biophys J 31: 245-256, 2002
61. 2+ sensitivity of rat myofibrils. J Biol Chem 272: 26887-6892, 1997
62. 2- and COOH-terminal regions of skeletal muscle troponin I. J Biol Chem 269: 5230-5240, 1994
63. Murphy AM, Kogler H, Georgakopoulos D, McDonough JL, Kass DA, Van Eyk JE, Marban E: Transgenic mouse model of stunned myocardium. Science 287: 488-491, 2000
64. Syska H, Wilkinson JM, Grand RJ, Perry SV: The relationship between biological activity and primary structure of troponin I from white skeletal muscle of the rabbit. Biochem J 153: 375-387, 1976
65. Talbot JA, Hodges RS: Synthesis and biological activity of an icosapeptide analog of the actomyosin ATPase inhibitory region of troponin I. J Biol Chem 254: 3720-3723, 1979
66. Talbot JA, Hodges RS: Comparative studies on the inhibitory region of selected species of troponin-I. The use of synthetic peptide analogs to probe structure-function relationships. J Biol Chem 256: 12374-12378, 1981
67. Van Eyk JE, Hodges RS: The biological importance of each amino acid residue of the troponin I inhibitory sequence 104-115 in the interaction with troponin C and tropomyosin-actin. J Biol Chem 263: 1726-1732, 1988
68. Levine BA, Moir AJ, Perry SV: The interaction of troponin-I with the N-terminal region of actin. Eur J Biochem 172: 389-397, 1988
69. 2- and COOH-terminal domains of the inhibitory region of troponin I in the regulation of skeletal muscle contraction. J Biol Chem 274: 29536-29542, 1999
70. 2+-dependent regulation of muscle contraction. J Mol Biol 271: 728-750, 1997
71. 2+ sensitivity of the acto-S1-TM ATPase activity of the thin filament. J Biol Chem 272: 10529-10537, 1997
72. D'Cruz LG, Baboonian C, Phillimore HE, Taylor R, Elliott PM, Varnava A, Davison F, McKenna WJ, Carter ND: Cytosine methylation confers instability on the cardiac troponin T gene in hypertrophic cardiomyopathy. J Med Genet E 37: 18, 2000
73. Buja G, Miorelli M, Turrini P, Melacini P, Nava A: Comparison of QT dispersion in hypertrophic cardiomyopathy between patients with and without ventricular arrhythmias and sudden death. Am J Cardiol 72: 973-976, 1993
74. Shimizu M, Ino H, Okeie K, Yamaguchi M, Nagata M, Hayashi K, Ito H, Iwaki T, Oe K, Konno T, Mabuchi H: T-peak to T-end interval may be a better predictor of high-risk patients with hypertrophic cardiomyopathy associated with a cardiac troponin I mutation than QT dispersion. Clin Cardiol 25: 335-339, 2002
75. Naimi B, Harrison A, Cummins M, Nongthomba U, Clark S, Canal I, Ferrus A, Sparrow JC: A tropomyosin-2 mutation suppresses a troponin I myopathy in Drosophila. Mol Biol Cell 12: 1529-1539, 2001
76. Kronert WA, Acebes A, Ferrus A, Bernstein SI: Specific myosin heavy chain mutations suppress troponin I defects in Drosophila muscles. J Cell Biol 144: 989-1000, 1999
77. Mogensen J, Kubo T, Duque M, Uribe W, Shaw A, Murphy R, Gimeno JR, Elliott P, McKenna WJ: Idiopathic restrictive cardiomyopathy is part of the clinical expression of cardiac troponin I mutations. J Clin Invest 111: 209-216, 2003
78. Seidman CE, Seidman JG: Molecular genetic studies of familial hypertrophic cardiomyopathy. Basic Res Cardiol 93(suppl 3):13-16, 1998
79. Watkins H, Seidman CE, Seidman JG, Feng HS, Sweeney HL: Expression and functional assessment of a truncated cardiac troponin T that causes hypertrophic cardiomyopathy. Evidence for a dominant negative action. J Clin Invest 98: 2456-2461, 1996
80. Grand RJ, Wilkinson JM: The amino acid sequence of rabbit cardiac troponin I. Biochem J 159: 633-641, 1976
81. Wilkinson JM, Grand RJ: Comparison of amino acid sequence of troponin I from different striated muscles. Nature 271: 31-35, 1978